CASTLEARK MANAGEMENT LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
CASTLEARK MANAGEMENT LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$3,055,705
-39.4%
85,690
+12.7%
0.14%
-25.4%
Q4 2021$5,040,000
+9.2%
76,020
+2.8%
0.18%
+4.5%
Q3 2021$4,617,000
-28.3%
73,960
-4.8%
0.18%
-18.1%
Q2 2021$6,435,000
+44.5%
77,700
+15.7%
0.22%
+35.0%
Q1 2021$4,454,000
-11.4%
67,165
+2.6%
0.16%
-14.9%
Q4 2020$5,025,000
+46.4%
65,490
-17.9%
0.19%
+39.3%
Q3 2020$3,433,00079,7300.14%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,303$54,386,00028.54%
JOHNSON & JOHNSON 3,260,869$216,196,00024.61%
ACT CAPITAL MANAGEMENT, LLC 210,500$13,956,00010.09%
Aquilo Capital Management, LLC 700,426$46,438,0005.27%
WEALTH EFFECTS LLC 145,960$9,677,0004.02%
Evolutionary Tree Capital Management, LLC 115,580$7,663,0003.68%
ACUTA CAPITAL PARTNERS, LLC 105,500$6,995,0002.94%
Privium Fund Management B.V. 204,393$13,766,0002.73%
L1 Capital Pty Ltd 292,735$19,408,0002.24%
Avidity Partners Management LP 875,000$58,013,0001.23%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders